Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 48, Issue 9, 2003, Pages 2519-2523

  Thorburn, Christine M ^a   Ward, Michael M ^a,b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c National Institute of Musculoskeletal and Skin Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART CATHETERIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

COMORBIDITY; CORONARY ARTERIOSCLEROSIS; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS; UNITED STATES;

EID: 0141676427     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11241     Document Type: Article

References (15)

1. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989;68:141-50.
2. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997;145:408-15.
3. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:338-46.
4. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritic C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
5. National Technical Information Service. Overview of the health-care cost and utilization project nationwide inpatient sample (NIS). Springfield (VA): Agency for Healthcare Research and Quality; 2001.
6. HCIA. The international classification of diseases, 9th revision, clinical modification: ICD-9-CM. 10th ed. Baltimore: HCIA; 1993.
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
8. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
9. Ward MM. Hospital experience and mortality in patients with systemic lupus erythematosus. Arthritis Rheum 1999;42:891-8.
10. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-9.
11. Rahman P, Urowitz MB, Gladman DD, Bruce IN, Genest J Jr. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol 1999;26:2363-8.
12. Lopes-Virella MF, Virrella GT. Atherosclerosis and autoimmunity. Clin Immunol Immunopathol 1994;73:155-67.
13. Svenungsson E, Jensen-Urstad K, Heimbürger M, Silveira A, Hamsten A, de Faire U, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001;104:1887-93.
14. Bruce IN, Gladman DD, Urowitz MB. Detection and modification of risk factors for coronary artery disease in patients with SLE: a quality improvement study. Clin Exp Rheumatol 1998;16:435-40.
15. Liang MJ, Mandl LA, Costenbader K, Fox E, Karlson E. Atherosclerotic vascular disease in systemic lupus erythematosus. J Natl Med Assoc 2002;94:813-9.